Sign in

CIK 0001752828

  • Emerging growth company

Celularity Inc

Sign in to watch
Ticker
CELU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831702591
Phone
+1 908-768-2170
Business address
170 PARK AVE, FLORHAM PARK, NJ, 07932
Former names
GX Acquisition Corp.
  1. 4 Grant or award Director acquired 125,000 shares (grant or award)
  2. 4 Grant or award Director acquired 125,000 shares (grant or award)
  3. 4 Grant or award Director acquired 125,000 shares (grant or award)
  4. 4 Grant or award Director acquired 125,000 shares (grant or award)
  5. 4 Grant or award Director acquired 67,416 shares (grant or award)
  6. 4 Grant or award Director acquired 67,416 shares (grant or award)
  7. 4 Grant or award Director acquired 67,416 shares (grant or award)
  8. 4 Grant or award Director acquired 61,539 shares (grant or award)
  9. 4 Grant or award Director acquired 3,699 shares (grant or award)
  10. 4 Grant or award Director acquired 44,379 shares (grant or award)
  11. 4 Grant or award Director acquired 47,042 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4/A Shares withheld for taxes Chief Executive Officer gave up 1,154 shares (to pay taxes)
  17. 4 Shares withheld for taxes Pres., Functional Regeneration gave up 268 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Executive Officer gave up 1,154 shares (to pay taxes)
  19. 4 Shares withheld for taxes Senior Exec Vice President gave up 577 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Financial Officer gave up 360 shares (to pay taxes)

Page 2 of 10 · 191 filings